Cited by 456Health Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and PolicyStatistical Methods in Clinical Trials

A rational framework for decision making by the National Institute for Clinical Excellence (NICE)

Claxton, Karl, Sculpher, Mark, Drummond, Michael·2002·The Lancet

Abstract

Regulatory and reimbursement authorities face uncertain choices when considering the adoption of health-care technologies. In this Viewpoint, we present an analytic framework that separates the issue of whether a technology should be adopted on the basis of existing evidence from whether more research should be demanded to support future decisions. We show the application of this framework to the assessment of heath-care technologies using a published analysis of a new drug treatment for Alzheimer's disease. The results of the analysis show that the amount and type of evidence required to support the adoption of a health technology will differ substantially between technologies with different characteristics. Additionally, the analysis can be used to aid the efficient design of research. We discuss the implications of adoption of this new framework for regulatory and reimbursement decisions.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(02)09832-x

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The expected value of perfect information (EVPI) is perhaps the best measure of uncertainty surrounding a particular decision in cost-effectiveness analysis, since it combines the probability of incorrect decision making with the consequential loss function.

    “Perhaps the best measure of uncertainty surrounding a particular decision in cost-effectiveness analysis is the EVPI, since this measure combines the probability of incorrect decision making with the consequential loss function [28].”

The citation lists haven’t been fetched yet

References 19 · Cited by 456

Authors
Claxton, K., Sculpher, M., & Drummond, M.
Affiliations
University of York (GB)
Corresponding author
Claxton, Karl
Venue
The Lancet
Publisher
Elsevier BV
Published
2002-08
Volume
360
Issue
9334
Pages
711-715
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2159390189
Cited by
456
References
19
Citations by year
2026: 4 · 2025: 3 · 2024: 6 · 2023: 6 · 2022: 10 · 2021: 7 · 2020: 7 · 2019: 21 · 2018: 16 · 2017: 26 · 2016: 19 · 2015: 21 · 2014: 18 · 2013: 24 · 2012: 19
FWCI
38.18
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • DigitalGeorgetown (Georgetown University Library) (submittedVersion)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Keywords
health technology assessment, Nice, decision-making, analytical framework, research needs, regulatory decision-making, reimbursement decisions, Alzheimer's disease, pharmacotherapy, research design
MeSH terms
Alzheimer Disease, Decision Support Techniques, Diffusion of Innovation, Drug and Narcotic Control, United Kingdom, Humans, Reimbursement Mechanisms, Research Design, State Medicine, Drugs, Investigational, Randomized Controlled Trials as Topic, Drug Approval

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review